Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy

Blood

Volumn 128, Issue 2, 2016, Pages 253-264

  Moschoi, Ruxanda ^a,b   Imbert, Véronique ^a,b   Nebout, Marielle ^a,b   Chiche, Johanna ^a,b   Mary, Didier ^a,b   Prebet, Thomas ^c   Saland, Estelle ^d   Castellano, Rémy ^e,f,g   Pouyet, Laurent ^e,f,g   Collette, Yves ^e,f,g   Vey, Norbert ^c   Chabannon, Christian ^c   Recher, Christian ^d   Sarry, Jean Emmanuel ^d   Alcor, Damien ^a,b   Peyron, Jean François ^a,b   Griessinger, Emmanuel ^a,b  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f CNRS   (France)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATP6 PROTEIN; ATP8 PROTEIN; BIOLOGICAL MARKER; BUSULFAN; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CYTARABINE; CYTOCHROME B; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE I; CYTOCHROME C OXIDASE II; CYTOCHROME C OXIDASE III; DOXORUBICIN; ETOPOSIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN RPLP0; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE MYELOID LEUKEMIA; ACUTE MYELOID LEUKEMIA CELL LINE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL LINE; BONE MARROW STROMA CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER TRANSPLANTATION; CD3+ T LYMPHOCYTE; CELL CONTACT; CELL MEMBRANE DEPOLARIZATION; CELL PROTECTION; CELL SIZE; CELL SURVIVAL; CELL TRANSFER; COCULTURE; CONTROLLED STUDY; ENDOCYTOSIS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MITOCHONDRIAL TRANSFER; MITOCHONDRION; MOUSE; MYELOBLAST; NONHUMAN; NORMAL HUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; THERAPEUTIC INDEX; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; UMBILICAL CORD BLOOD CELL; XENOTRANSPLANTATION; ANIMAL; BONE MARROW CELL; HL-60 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; STROMA CELL; U-937 CELL LINE; XENOGRAFT;

ANIMALS; BONE MARROW CELLS; COCULTURE TECHNIQUES; HETEROGRAFTS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, NUDE; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; STROMAL CELLS; U937 CELLS;

EID: 85016250962     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-07-655860     Document Type: Article

References (25)

1. McCulloch EA, Howatson AF, Buick RN, Minden MD, Izaguirre CA. Acute myeloblastic leukemia considered as a clonal hemopathy. Blood Cells. 1979;5(2):261-282.
2. Fialkow PJ, Singer JW, Raskind WH, et al. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med. 1987;317(8):468-473.
3. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737.
4. Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657-667.
5. Huff CA, Matsui W, Smith BD, Jones RJ. The paradox of response and survival in cancer therapeutics. Blood. 2006;107(2):431-434.
6. Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M. Stromal cells prevent apoptosis of AML cells by up-regulation of antiapoptotic proteins. Leukemia. 2002;16(9):1713-1724.
7. Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z, Andreeff M. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood. 2009;113(7):1504-1512.
8. Derdak Z, Mark NM, Beldi G, Robson SC, Wands JR, Baffy G. The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res. 2008;68(8):2813-2819.
9. Samudio I, Fiegl M, McQueen T, Clise-Dwyer K, Andreeff M. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res. 2008;68(13):5198-5205.
10. Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759-765.
11. Pasquier J, Guerrouahen BS, Al Thawadi H, et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med. 2013;11:94.
12. Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22(7):1181-1191.
13. Griessinger E, Anjos-Afonso F, Pizzitola I, et al. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms. Stem Cells Transl Med. 2014;3(4):520-529.
14. Herst PM, Berridge MV. Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta. 2007;1767(2):170-177.
15. Lassailly F, Griessinger E, Bonnet D. "Microenvironmental contaminations" induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking. Blood. 2010;115(26):5347-5354.
16. Tait SW, Parsons MJ, Llambi F, et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev Cell. 2010;18(5):802-813.
17. Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, Zervos AS. Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem. 2000;275(4):2581-2588.
18. Gray CW, Ward RV, Karran E, et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem. 2000;267(18):5699-5710.
19. Taussig DC, Miraki-Moud F, Anjos-Afonso F, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 2008;112(3):568-575.
20. Taussig DC, Vargaftig J, Miraki-Moud F, et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood. 2010;115(10):1976-1984.
21. Eppert K, Takenaka K, Lechman ER, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17(9):1086-1093.
22. Sarry JE, Murphy K, Perry R, et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. J Clin Invest. 2011;121(1):384-395.
23. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029-1033.
24. Martinez-Outschoorn UE, Pavlides S, Howell A, et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol. 2011;43(7):1045-1051.
25. Ahmad T, Mukherjee S, Pattnaik B, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 2014;33(9):994-1010.